[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624228":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":31,"centralContacts":38,"locations":48,"responsibleParty":67,"collaborators":31,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":31,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":31,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":90,"whyStopped":31,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"The Hong Kong Polytechnic University","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"High concentration group","EXPERIMENTAL","3 active capsules\u002F per day",[13],"Dietary Supplement: Oral dietary supplement provided in a capsule format (3 active capsules\u002F per day)",{"label":15,"type":10,"description":16,"interventionNames":17},"Low-concentration group","1 active capsule and 2 placebo capsules\u002Fper day",[18],"Dietary Supplement: Oral dietary supplement provided in a capsule format (1 active capsule and 2 placebo capsules\u002Fper day)",{"label":20,"type":21,"description":22,"interventionNames":23},"Control group","PLACEBO_COMPARATOR","3 placebo capsules\u002Fper day",[24],"Other: Placebo control (3 placebo capsules\u002Fper day)",[26,32,35],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"DIETARY_SUPPLEMENT","Oral dietary supplement provided in a capsule format (3 active capsules\u002F per day)","The active intervention in this study is an oral dietary supplement provided in a capsule format. The active ingredients include DHA\u002FEPA and Astaxanthin.",[9],null,{"type":27,"name":33,"description":29,"armGroupLabels":34,"otherNames":31},"Oral dietary supplement provided in a capsule format (1 active capsule and 2 placebo capsules\u002Fper day)",[15],{"type":6,"name":36,"description":22,"armGroupLabels":37,"otherNames":31},"Placebo control (3 placebo capsules\u002Fper day)",[20],[39,44],{"name":40,"role":41,"phone":42,"phoneExt":31,"email":43},"Xiaojie WAN, MD","CONTACT","+852 8496 7212","xiaojie.wan@connect.polyu.hk",{"name":45,"role":41,"phone":46,"phoneExt":31,"email":47},"Yue WU, MD","+852 5171 7556","yuewy.wu@connect.polyu.hk",[49],{"facility":50,"status":31,"city":51,"state":31,"zip":31,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"Hong Kong Polytechnic University","Hong Kong","HK",{"type":54,"coordinates":55},"Point",[56,57],114.17469,22.27832,{"lat":57,"lon":56},[60,64],{"name":61,"role":41,"phone":62,"phoneExt":31,"email":63},"PolyU Institutional Review Board","+852 2766 6379","institutional.review.board@polyu.edu.hk",{"name":65,"role":66,"phone":31,"phoneExt":31,"email":31},"Mingguang HE","PRINCIPAL_INVESTIGATOR",{"type":68,"investigatorFullName":31,"investigatorTitle":31,"investigatorAffiliation":31,"oldNameTitle":31,"oldOrganization":31},"SPONSOR","100624228","dietary-supplement-for-myopia-control-100624228",false,"NCT07406906","Dietary Supplement for Myopia Control","The Effect of Dietary Supplements on Choroidal Thickness and Vasculature in Myopic Children: A Randomized, Double-Blind, Placebo-Controlled Trial","Inclusion Criteria:\n\n* Age 8-13 years\n* Cycloplegic spherical equivalent refraction (SER) of -0.50 D to -5.00 D with astigmatism of 2.5 D or less and best-corrected visual acuity (BCVA) of 0.0 logarithm or more in either eye\n* Anisometropia of 1.50 D or less\n* Intraocular pressure of 10 mmHg to 21 mmHg in both eyes\n* Willing to give written consent to participate in the study and accept random allocation in grouping\n\nExclusion Criteria:\n\n* Ocular abnormalities leading to visual impairment\n* Severe physiological and psychological diseases affecting follow-up\n* Receiving previous myopia control treatment including but not limited to atropine therapy and orthokeratology in the past 3 months\n* Use of any other dietary supplements containing DHA\u002FEPA, Lutein, or Astaxanthin in the past 3 months\n* Known history of allergy to any of the components of the dietary supplement or placebo, or history of an allergic reaction that required emergency treatment\n* Children who had other contraindications identified by the investigators that made them unsuitable for participation","ALL","8 Years","13 Years",{"count":80,"type":81},156,"ESTIMATED","INTERVENTIONAL",[84],"NA","The purpose of this clinical trial is to investigate the changes in choroidal thickness and vasculature in myopic children following oral supplementation.",[87],"Myopia",[89],"oral supplements, choroidal thickness, choroidal blood flow","NOT_YET_RECRUITING","2026-07-23",{"date":93,"type":94},"2026-07-24","ACTUAL",{"date":96,"type":81},"2026-08-01",{"date":98,"type":81},"2026-12-30",{"name":5,"class":6},1]